bioMérieux S.A. (0RUG.L)
bioMérieux S.A.
376 Chemin De l’Orme
Marcy-l'Étoile 69280
France
33 4 78 87 20 00
https://www.biomerieux.com
Sector(es):
Industria:
Empleados a tiempo completo: 13,409
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Pierre Boulud | Chief Executive Officer | 1.35M | N/D | 1971 |
| Mr. Guillaume Bouhours | Executive VP of Purchasing and Information Systems & CFO | N/D | N/D | 1976 |
| Sylvain Morgeau | Investor Relations | N/D | N/D | N/D |
| Ms. Audrey Dauvet | Executive Vice President of Legal, Corporate Integrity & Public Affairs | N/D | N/D | 1974 |
| Ms. Valerie Leylde | Executive Vice President of Human Resources, Communications & CSR | N/D | N/D | N/D |
| Mr. Pierre Charbonnier | Executive Vice President of Global Quality, Manufacturing & Supply Chain | N/D | N/D | N/D |
| Mr. Yasha Mitrotti | Executive Vice President of Industrial Applications | N/D | N/D | N/D |
| Mr. Frederic Beseme | Head of CSR | 21.99k | N/D | 1956 |
| Jennifer Zinn | Executive Vice President of Clinical Operations | N/D | N/D | N/D |
| Dr. Charles K. Cooper | Executive VP & Chief Medical Officer | N/D | N/D | N/D |
Descripción
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Gestión corporativa
La calificación ISS Governance QuickScore de bioMérieux S.A. a partir del 1 de julio de 2024 es 8. Las puntuaciones principales son Auditoría: 5; Junta: 7; Derechos del accionista: 8; Compensación: 9.
